BIOTIE THERAPIES CORP SPONSORED ADR
BITI
BITI was delisted on the 10th of June, 2016.
0 hedge funds and large institutions have $0 invested in BIOTIE THERAPIES CORP SPONSORED ADR in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 19 closing their positions.
100% less funds holding
Funds holding: 19 → 0 (-19)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $98.5M → $0 (-$98.5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 19
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$36.8M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$32.5M |
| 3 |
VVM
Versant Venture Management
San Francisco,
California
|
-$7.09M |
| 4 |
O
OrbiMed
New York
|
-$7.09M |
| 5 |
Morgan Stanley
New York
|
-$4.04M |
BITI Hedge Fund Activity: Q2 2016 in Review
0 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in BIOTIE THERAPIES CORP SPONSORED ADR (BITI) for Q2 2016, worth a combined $0 — down 100% from $98.5M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of BITI and 0 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Baupost Group, exiting entirely with an estimated $36.8M sold.
- 0 institutional investors held BIOTIE THERAPIES CORP SPONSORED ADR (BITI) as of Q2 2016, down from 19 in Q1 2016.
- Funds reported $0 of BIOTIE THERAPIES CORP SPONSORED ADR stock for Q2 2016, down 100% quarter-over-quarter.
- 0 funds opened new BIOTIE THERAPIES CORP SPONSORED ADR positions in Q2 2016 and 19 closed out, a net change of -19 holders.
- The largest BIOTIE THERAPIES CORP SPONSORED ADR seller in Q2 2016 was Baupost Group, an estimated $36.8M sold.
Based on aggregated 13F filings for Q2 2016.